News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Agenus Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Genetown
2 Under-the-Radar Cancer Stocks That are in the Bargain Bin Right Now
August 19, 2016
·
3 min read
Bio NC
7 Biotech Stocks Investors Should Keep Their Eye On in 2017
August 3, 2016
·
3 min read
Deals
Looking at the Odds, Pfizer, Incyte or Merck & Co. Will Gobble Up Tiny Agenus
June 14, 2016
·
3 min read
Genetown
2 Potentially Hot Biotech Stocks Currently Under $5 Per Share
May 31, 2016
·
3 min read
Genetown
Organovo’s 3D Bioprinting May Be Sexy, But Agenus and Sorrento May Be Better Buys
March 2, 2016
·
4 min read
Drug Development
Agenus Acquires PhosImmune in $44.9 Million Deal
December 28, 2015
·
2 min read
Genetown
Agenus Trades Away Future Royalties on Sales of GlaxoSmithKline Drug for $115 Million
September 9, 2015
·
2 min read
Business
Incyte Corporation, Agenus Strike $410 Million+ Immuno-Oncology Antibodies Pact
January 9, 2015
·
2 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Agenus Expands Medical Affairs Infrastructure to Support Increasing Physician Requests for Authorized Access to Botensilimab Plus Balstilimab
January 21, 2026
·
8 min read
Press Releases
Agenus to Host First 2026 Stakeholder Webcast
January 21, 2026
·
5 min read
Press Releases
Agenus Announces Closing of $141M Strategic Collaboration with Zydus Lifesciences to Advance BOT+BAL and Strengthen U.S. Manufacturing Readiness
January 16, 2026
·
8 min read
Press Releases
Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.
January 16, 2026
·
3 min read
Press Releases
France Expands National AAC Access for Agenus’ Botensilimab + Balstilimab for Ovarian Cancer and Soft-Tissue Sarcomas
January 12, 2026
·
7 min read
Press Releases
Agenus Reports Deep, Durable Responses with Botensilimab + Balstilimab in Highly Refractory Ovarian Cancer, Published in JITC
December 24, 2025
·
8 min read
Press Releases
Agenus to Host End-of-Year Stakeholder Webcast Featuring GI Oncology Leaders and Progress of BOT/BAL
November 20, 2025
·
5 min read
Press Releases
Agenus Appoints Dr. José Iglesias as Chief Medical Affairs Officer to Guide Global Medical Affairs and Early-Access Programs, Including France’s AAC
November 19, 2025
·
6 min read
Press Releases
Agenus Reports Q3 2025 Results Showcasing Clinical and Regulatory Advances
November 11, 2025
·
7 min read
Press Releases
Agenus to Provide Corporate Update and Third Quarter 2025 Financial Report
November 5, 2025
·
2 min read
